Clinical Trial Update: Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for intravenous GMI-1070 in adults with sickle cell disease (Phase 1/Phase 2) has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• GMI-1070

Snippet

Sponsor: GlycoMimetics Incorporated | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-05-03